Navigation Links
EraGen cystic fibrosis test to be distributed worldwide through Bayer

EraGen Biosciences in Madison landed an exclusive worldwide distribution agreement for its new cystic fibrosis assay, MultiCode PLx, to the Diagnostics Division of Bayer HealthCare LLC.

The new assay can be automated for mutation carrier screening and neonatal and newborn testing. The agreement also allows Bayer Hea......

Full article >>> automation, decreased hands-on time, and less involvement of very skilled workers."

This latest agreement is but the next time in a continuing relationship between the two companies: Bayer has incorporated EraGen's core technology into its own proprietary applications for HIV and hepatitis tests. Those applications have FDA approval and have been on the market for about five years.
<......

Full article >>>
'"/>

Source:wistechnology.com By Lincoln Brunner 05/18/05


Related biology technology :

1. EraGen set to highlight diagnostic products at BIO
2. EraGen diagnostic passes UW tests, could quickly detect bird flu
3. EraGen lands $12 million venture round
4. EraGen gets $250,000 state loan to revamp manufacturing facility
5. EraGen strikes big distribution deal; Berbee buys again
6. EraGens SARS test validated by Chinese agency
7. EraGen collaborates with Emory University on HIV detection system
8. EraGen signs Canadian Market Distribution Agreement for nucleic acid dection products
9. Promega and EraGen sign technology licensing agreement
10. EraGens Revolutionary Genomic-Based Technologies
11. EraGen Expands in Japan
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/17/2017)... (PRWEB) , ... January 17, 2017 , ... ... completely re-engineered Drug Safety Technology Consortium™ (SafeTEC™), $3 million in investment towards 15+ ... these new tools and assays, and their applicability in drug safety assessment, for ...
(Date:1/17/2017)... MILPITAS, Calif. , Jan. 17, 2017 /PRNewswire/ ... today announced that it has initiated a global ... PTG-100, an oral peptide that targets alpha4beta7 integrin. ... design study is to evaluate the safety/tolerability and ... colitis patients with moderate to severe active disease. ...
(Date:1/16/2017)... , Jan. 16, 2017   Valentin A. ... Tracey, MD , president and CEO of The ... completed an analysis of how the nervous system regulates ... and develop bioelectronic medicine devices to treat ... Nature Neuroscience . The paper examines ...
(Date:1/14/2017)... ... January 14, 2017 , ... Seattle-based ... complete end-to-end genome assemblies to researchers around the globe. Long considered a ... in answering a wide range of scientific questions. The announcement was made ...
Breaking Biology Technology:
(Date:1/3/2017)... Jan. 3, 2017 Onitor, provider of digital ... Onitor Track, an innovative biometric data-driven program designed to ... month at the 2017 Consumer Electronics Show (CES) in ... In the U.S., the World Health Organization (WHO), have ... of adults who are overweight or obese. WHO also ...
(Date:12/19/2016)... y TORONTO , 19 de diciembre de 2016 ... Inc. que permitirá el desarrollo acelerado de MSC-1, un anticuerpo humanizado ... tipos de tumor en 2017, con múltiples sitios previstos a lo ... ... objetivo en el factor inhibidor de leucemia (LIF), una citoquina pleiotrópica ...
(Date:12/15/2016)... , Dec. 15, 2016   WaferGen Bio-systems, ... held genomics technology company, announced today that on December ... Qualifications Department of The Nasdaq Stock Market LLC which ... bid price of WaferGen,s common stock had been at ... WaferGen has regained compliance with Listing Rule 5550(a)(2) of ...
Breaking Biology News(10 mins):